FDA Warns 5 Companies for Marketing CBD Edibles
Credit: Simone
The U.S. Food and Drug Administration today posted warning letters to five companies for illegally selling products containing cannabidiol (CBD).
These companies are accused of selling products containing CBD that the FDA states some people may confuse for traditional foods or beverages that do not contain CBD. This could result in unintentional consumption or overconsumption of CBD.
“CBD-containing products in forms that are appealing to children, such as gummies, hard candies and cookies, are especially concerning,” the FDA stated in a release.
Warning letters were sent to the following companies:
The FDA has not found adequate information showing how much CBD can be consumed, and for how long, before causing harm, according to the agency.
“This is particularly true for vulnerable populations like children and those who are pregnant. People should be aware of the potential risks associated with the use of CBD products,” the agency states.
The warning letters also outline additional violations of the Food, Drug & Cosmetics Act, including that several of the companies are illegally selling unapproved CBD products that claim to cure, mitigate, treat or prevent various diseases, and adding CBD to animal foods, such as pet treats.
“The FDA has requested responses from the companies within 15 working days stating how they will address the issues described in the warning letters or providing their reasoning and supporting information as to why they think the products are not in violation of the law,” the agency wrote. “Failure to adequately address the violations promptly may result in legal action, including product seizure and/or injunction.”
